Follow
Rafael Ramirez Morales
Title
Cited by
Cited by
Year
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis
S Moran, A Martínez-Cardús, S Sayols, E Musulén, C Balañá, ...
The Lancet Oncology 17 (10), 1386-1395, 2016
4232016
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study
A Vitale, RR Morales, G Zanus, F Farinati, P Burra, P Angeli, AC Frigo, ...
The lancet oncology 12 (7), 654-662, 2011
1702011
Neurosteroid biosynthetic pathways changes in prefrontal cortex in Alzheimer's disease
S Luchetti, K Bossers, S Van de Bilt, V Agrapart, RR Morales, GV Frajese, ...
Neurobiology of aging 32 (11), 1964-1976, 2011
1182011
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list
A Vitale, ML Volk, TM De Feo, P Burra, AC Frigo, RR Morales, L De Carlis, ...
Journal of hepatology 60 (2), 290-297, 2014
932014
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: The ITA. LI. CA database
A Vitale, G Svegliati-Baroni, A Ortolani, M Cucco, GV Dalla Riva, ...
Gut 72 (1), 141-152, 2023
692023
In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and …
L Artigas, M Coma, P Matos-Filipe, J Aguirre-Plans, J Farrés, R Valls, ...
PLoS One 15 (10), e0240149, 2020
642020
SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis
C Turato, A Vitale, S Fasolato, M Ruvoletto, L Terrin, S Quarta, ...
British journal of cancer 110 (11), 2708-2715, 2014
642014
Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on “number of patients needed to transplant” as measure of …
A Vitale, A Cucchetti, GL Qiao, M Cescon, J Li, RR Morales, AC Frigo, ...
Journal of hepatology 60 (6), 1165-1171, 2014
602014
Use of N‐acetylcysteine during liver procurement: A prospective randomized controlled study
F D'Amico, A Vitale, D Piovan, A Bertacco, R Ramirez Morales, ...
Liver Transplantation 19 (2), 135-144, 2013
582013
Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation?
A Vitale, P Boccagni, X Kertusha, G Zanus, F D'Amico, E Lodo, ...
Transplantation proceedings 44 (7), 1989-1991, 2012
402012
Sequencing of taxanes and new androgen-targeted therapies in metastatic castration-resistant prostate cancer: results of the international multicentre retrospective CATS database
N Delanoy, AC Hardy-Bessard, E Efstathiou, S Le Moulec, U Basso, ...
European urology oncology 1 (6), 467-475, 2018
352018
Very early introduction of everolimus in de novo liver transplantation: results of a multicenter, prospective, randomized trial
U Cillo, L Saracino, A Vitale, A Bertacco, M Salizzoni, F Lupo, M Colledan, ...
Liver Transplantation 25 (2), 242-251, 2019
342019
Liver Transplantation North Italy Transplant program (NITp) working group. A method for establishing allocation equity among patients with and without hepatocellular carcinoma …
A Vitale, ML Volk, TM De Feo, P Burra, AC Frigo, R Ramirez Morales, ...
J Hepatol 60 (2), 290-7, 2014
302014
Italian Liver Cancer group. Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study
A Vitale, RR Morales, G Zanus, F Farinati, P Burra, P Angeli, AC Frigo, ...
Lancet Oncol 12 (7), 654-62, 2011
232011
Sexual dimorphic evolution of metabolic programming in non-genetic non-alimentary mild metabolic syndrome model in mice depends on feed-back mechanisms integrity for pro …
S Loizzo, S Vella, A Loizzo, A Fortuna, A Di Biase, S Salvati, GV Frajese, ...
Peptides 31 (8), 1598-1605, 2010
172010
Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation
A Vitale, RR Morales, E Dalla Bona, M Scopelliti, G Zanus, D Neri, ...
Transplantation proceedings 43 (4), 974-976, 2011
162011
Model for end‐stage liver disease‐sodium and survival benefit in liver transplantation
A Vitale, A Bertacco, M Gambato, F D'Amico, RR Morales, AC Frigo, ...
Transplant International 26 (2), 138-144, 2013
122013
Molecular refinement of clinical staging in hepatocellular carcinoma patients evaluated for potentially curative therapies
A Vitale, F Navaglia, R Ramírez Morales, AC Frigo, D Basso, F D'Amico, ...
PloS one 6 (9), e23093, 2011
72011
Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database
N Delanoy, AC Hardy-Bessard, E Efstathiou, S Le Moulec, U Basso, ...
European Journal of Cancer 125, 153-163, 2020
62020
Potential impact of sorafenib on the survival benefit of liver transplantation for hepatocellular carcinoma
A Vitale, G Lombardi, RR Morales, U Cillo
Digestive and Liver Disease 44 (5), 361-362, 2012
62012
The system can't perform the operation now. Try again later.
Articles 1–20